Skip to main content

Advertisement

Log in

Symptom clusters and quality of life in ambulatory patients with multiple myeloma

  • Original Article
  • Published:
Supportive Care in Cancer Aims and scope Submit manuscript

Abstract

Purpose

The aim of this study was to investigate symptom clusters and associated clinical factors in ambulatory multiple myeloma patients undergoing medication therapy. We also aimed to determine the correlations between symptom clusters and patient quality of life.

Methods

A total of 174 multiple myeloma patients hospitalized in the haematology day unit were included in this study. A cross-sectional survey was conducted to examine symptoms and quality of life. Symptoms were assessed by the Chinese version of the Condensed Memorial Symptom Assessment Scale. Quality of life was measured with the Functional Assessment of Cancer Therapy-General. Principal component analysis was used to identify symptom clusters. Independent-samples t tests and chi-square tests were used for comparisons between groups. Spearman’s rank correlation analysis was used to identify correlations.

Results

We identified three symptom clusters in multiple myeloma patients: psychological; pain, dry mouth, and difficulty sleeping; and fatigue symptom cluster. For each symptom cluster, the patients could be categorized into a severe-symptom group or a mild-symptom group based on the distress of symptoms. The patients in each group exhibited differential demographic and clinical features. Symptom cluster distress was adversely correlated with patients’ quality of life.

Conclusions

Ambulatory multiple myeloma patients undergoing anticancer medication therapy experience multiple symptoms, which can be categorized into three symptom clusters. For each symptom cluster, level of distress was associated with patients’ demographic and clinical characteristics. The presence and level of distress of these symptom clusters have adverse impacts on patients’ quality of life.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Data availability

The data that support the findings of this study are available from the corresponding author upon reasonable request. The data are not publicly available due to privacy or ethical restrictions.

Code availability

Not applicable.

References

  1. Cowan AJ, Allen C, Barac A, Basaleem H, Bensenor I, Curado MP, Foreman K, Gupta R, Harvey J, Hosgood HD et al (2018) Global burden of multiple myeloma: a systematic analysis for the global burden of disease study 2016. JAMA Oncol 4(9):1221–1227. https://doi.org/10.1001/jamaoncol.2018.2128

    Article  PubMed  PubMed Central  Google Scholar 

  2. Siegel RL, Miller KD (2020) Jemal A (2020) Cancer statistics. CA Cancer J Clin 70(1):7–30. https://doi.org/10.3322/caac.21590

    Article  PubMed  Google Scholar 

  3. Rajkumar SV (2020) Multiple myeloma: 2020 update on diagnosis, risk-stratification and management. Am J Hematol 95(5):548–567. https://doi.org/10.1002/ajh.25791

    Article  CAS  PubMed  Google Scholar 

  4. Kumar SK, Jacobus SJ, Cohen AD, Weiss M, Callander N, Singh AK, Parker TL, Menter A, Yang X, Parsons B et al (2020) Carfilzomib or bortezomib in combination with lenalidomide and dexamethasone for patients with newly diagnosed multiple myeloma without intention for immediate autologous stem-cell transplantation (ENDURANCE): a multicentre, open-label, phase 3, randomised, controlled trial. Lancet Oncol 21(10):1317–1330. https://doi.org/10.1016/S1470-2045(20)30452-6

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Dodd M, Janson S, Facione N, Faucett J, Froelicher ES, Humphreys J, Lee K, Miaskowski C, Puntillo K, Rankin S et al (2001) Advancing the science of symptom management. J Adv Nurs 33(5):668–676. https://doi.org/10.1046/j.1365-2648.2001.01697.x

    Article  CAS  PubMed  Google Scholar 

  6. Barsevick AM, Whitmer K, Nail LM, Beck SL, Dudley WN (2006) Symptom cluster research: conceptual, design, measurement, and analysis issues. J Pain Symptom Manage 31(1):85–95. https://doi.org/10.1016/j.jpainsymman.2005.05.015

    Article  PubMed  Google Scholar 

  7. Russell J, Wong ML, Mackin L, Paul SM, Cooper BA, Hammer M, Conley YP, Wright F, Levine JD, Miaskowski C (2019) Stability of symptom clusters in patients with lung cancer receiving chemotherapy. J Pain Symptom Manage 57(5):909–922. https://doi.org/10.1016/j.jpainsymman.2019.02.002

    Article  PubMed  PubMed Central  Google Scholar 

  8. Li H, Sereika SM, Marsland AL, Conley YP, Bender CM (2020) Symptom clusters in women with breast cancer during the first 18 months of adjuvant therapy. J Pain Symptom Manage 59(2):233–241. https://doi.org/10.1016/j.jpainsymman.2019.10.002

    Article  PubMed  Google Scholar 

  9. Chen F, Leng Y, Zhang L, Xu J, Zhang D, Qin Y, Li J, Zheng Y (2020) The correlation of symptom clusters and functional performance in adult acute leukemia patients under chemotherapy. Cancer Nurs. https://doi.org/10.1097/NCC.0000000000000816

    Article  PubMed  Google Scholar 

  10. Kwekkeboom KL (2016) Cancer symptom cluster management. Semin Oncol Nurs 32(4):373–382. https://doi.org/10.1016/j.soncn.2016.08.004

    Article  PubMed  PubMed Central  Google Scholar 

  11. Jordan K, Proskorovsky I, Lewis P, Ishak J, Payne K, Lordan N, Kyriakou C, Williams CD, Peters S, Davies FE (2014) Effect of general symptom level, specific adverse events, treatment patterns, and patient characteristics on health-related quality of life in patients with multiple myeloma: results of a European, multicenter cohort study. Support Care Cancer 22(2):417–426. https://doi.org/10.1007/s00520-013-1991-4

    Article  PubMed  Google Scholar 

  12. Ramsenthaler C, Gao W, Siegert RJ, Edmonds PM, Schey SA, Higginson IJ (2019) Symptoms and anxiety predict declining health-related quality of life in multiple myeloma: a prospective, multi-centre longitudinal study. Palliat Med 33(5):541–551. https://doi.org/10.1177/0269216319833588

    Article  PubMed  Google Scholar 

  13. Ramsenthaler C, Kane P, Gao W, Siegert RJ, Edmonds PM, Schey SA, Higginson IJ (2016) Prevalence of symptoms in patients with multiple myeloma: a systematic review and meta-analysis. Eur J Haematol 97(5):416–429. https://doi.org/10.1111/ejh.12790

    Article  PubMed  Google Scholar 

  14. Palumbo A, Avet-Loiseau H, Oliva S, Lokhorst HM, Goldschmidt H, Rosinol L, Richardson P, Caltagirone S, Lahuerta JJ, Facon T et al (2015) Revised international staging system for multiple myeloma: a report from international myeloma working group. J Clin Oncol 33(26):2863–2869. https://doi.org/10.1200/JCO.2015.61.2267

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Chang VT, Hwang SS, Kasimis B, Thaler HT (2004) Shorter symptom assessment instruments: the Condensed Memorial Symptom Assessment Scale (CMSAS). Cancer Invest 22(4):526–536. https://doi.org/10.1081/cnv-200026487

    Article  PubMed  Google Scholar 

  16. Lam WW, Law CC, Fu YT, Wong KH, Chang VT, Fielding R (2008) New insights in symptom assessment: the Chinese Versions of the Memorial Symptom Assessment Scale Short Form (MSAS-SF) and the Condensed MSAS (CMSAS). J Pain Symptom Manage 36(6):584–595. https://doi.org/10.1016/j.jpainsymman.2007.12.008

    Article  PubMed  Google Scholar 

  17. Cella DF, Tulsky DS, Gray G, Sarafian B, Linn E, Bonomi A, Silberman M, Yellen SB, Winicour P, Brannon J et al (1993) The Functional Assessment of Cancer Therapy scale: development and validation of the general measure. J Clin Oncol 11(3):570–579. https://doi.org/10.1200/JCO.1993.11.3.570

    Article  CAS  Google Scholar 

  18. Yu CL, Fielding R, Chan CL, Tse VK, Choi PH, Lau WH, Choy DT, O SK, Lee AW, Sham JS, (2000) Measuring quality of life of Chinese cancer patients: a validation of the Chinese version of the Functional Assessment of Cancer Therapy-General (FACT-G) scale. Cancer 88(7):1715–1727

    Article  CAS  PubMed  Google Scholar 

  19. Barsevick A (2016) Defining the symptom cluster: how far have we come? Semin Oncol Nurs 32(4):334–350. https://doi.org/10.1016/j.soncn.2016.08.001

    Article  PubMed  Google Scholar 

  20. Lim KE, Kim SR, Kim HK, Kim SR (2017) Symptom clusters and quality of life in subjects with COPD. Respir Care 62(9):1203–1211. https://doi.org/10.4187/respcare.05374

    Article  PubMed  Google Scholar 

  21. Hauksdottir B, Klinke ME, Gunnarsdottir S, Bjornsdottir K (2017) Patients’ experiences with multiple myeloma: a meta-aggregation of qualitative studies. Oncol Nurs Forum 44(2):E64–E81. https://doi.org/10.1188/17.ONF.E64-E81

    Article  PubMed  Google Scholar 

  22. van der Poel MW, Oerlemans S, Schouten HC, van de Poll-Franse LV (2015) Elderly multiple myeloma patients experience less deterioration in health-related quality of life than younger patients compared to a normative population: a study from the population-based PROFILES registry. Ann Hematol 94(4):651–661. https://doi.org/10.1007/s00277-014-2264-0

    Article  PubMed  Google Scholar 

  23. Guo M, Wang C, Yin X, Nie L, Wang G (2019) Symptom clusters and related factors in oesophageal cancer patients 3 months after surgery. J Clin Nurs 28(19–20):3441–3450. https://doi.org/10.1111/jocn.14935

    Article  PubMed  Google Scholar 

  24. Rha SY, Park M, Lee J (2019) Stability of symptom clusters and sentinel symptoms during the first two cycles of adjuvant chemotherapy. Support Care Cancer 27(5):1687–1695. https://doi.org/10.1007/s00520-018-4413-9

    Article  PubMed  Google Scholar 

  25. Zucca AC, Boyes AW, Linden W, Girgis A (2012) All’s well that ends well? Quality of life and physical symptom clusters in long-term cancer survivors across cancer types. J Pain Symptom Manage 43(4):720–731. https://doi.org/10.1016/j.jpainsymman.2011.04.023

    Article  PubMed  Google Scholar 

  26. Mathias JL, Cant ML, Burke ALJ (2018) Sleep disturbances and sleep disorders in adults living with chronic pain: a meta-analysis. Sleep Med 52:198–210. https://doi.org/10.1016/j.sleep.2018.05.023

    Article  CAS  PubMed  Google Scholar 

  27. Krause AJ, Prather AA, Wager TD, Lindquist MA, Walker MP (2019) The pain of sleep loss: a brain characterization in humans. J Neurosci 39(12):2291–2300. https://doi.org/10.1523/JNEUROSCI.2408-18.2018

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Kiely F, Cran A, Finnerty D, O’Brien T (2017) Self-reported quality of life and symptom burden in ambulatory patients with multiple myeloma on disease-modifying treatment. Am J Hosp Palliat Care 34(7):671–676. https://doi.org/10.1177/1049909116646337

    Article  PubMed  Google Scholar 

  29. Zaleta AK, Miller MF, Olson JS, Yuen EYN, LeBlanc TW, Cole CE, McManus S, Buzaglo JS (2020) Symptom burden, perceived control, and quality of life among patients living with multiple myeloma. J Natl Compr Canc Netw 18(8):1087–1095. https://doi.org/10.6004/jnccn.2020.7561

    Article  PubMed  Google Scholar 

  30. Jean-Baptiste M, Gries KS, Lenderking WR, Fastenau J (2020) Symptom burden and health-related quality of life impacts of smoldering multiple myeloma: the patient perspective. J Patient Rep Outcomes 4(1):95. https://doi.org/10.1186/s41687-020-00253-2

    Article  PubMed  PubMed Central  Google Scholar 

  31. Xu X, Ou M, Xie C, Cheng Q, Chen Y (2019) Pain acceptance and its associated factors among cancer patients in Mainland China: a cross-sectional study. Pain Res Manag 2019:9458683. https://doi.org/10.1155/2019/9458683

    Article  PubMed  PubMed Central  Google Scholar 

  32. Santoso AMM, Jansen F, Lissenberg-Witte BI, Baatenburg de Jong RJ, Langendijk JA, Leemans CR, Smit JH, Takes RP, Terhaard CHJ, van Straten A et al (2021) Poor sleep quality among newly diagnosed head and neck cancer patients: prevalence and associated factors. Support Care Cancer 29(2):1035–1045. https://doi.org/10.1007/s00520-020-05577-9

    Article  PubMed  Google Scholar 

  33. Bartley EJ, Fillingim RB (2013) Sex differences in pain: a brief review of clinical and experimental findings. Br J Anaesth 111(1):52–58. https://doi.org/10.1093/bja/aet127

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Ohayon MM (2002) Epidemiology of insomnia: what we know and what we still need to learn. Sleep Med Rev 6(2):97–111. https://doi.org/10.1053/smrv.2002.0186

    Article  PubMed  Google Scholar 

  35. Feldman EL, Nave KA, Jensen TS, Bennett DLH (2017) New horizons in diabetic neuropathy: mechanisms, bioenergetics, and pain. Neuron 93(6):1296–1313. https://doi.org/10.1016/j.neuron.2017.02.005

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. Chen SY, Wang Y, Zhang CL, Yang ZM (2020) Decreased basal and stimulated salivary parameters by histopathological lesions and secretory dysfunction of parotid and submandibular glands in rats with type 2 diabetes. Exp Ther Med 19(4):2707–2719. https://doi.org/10.3892/etm.2020.8505

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Reutrakul S, Mokhlesi B (2017) Obstructive sleep apnea and diabetes: a state of the art review. Chest 152(5):1070–1086. https://doi.org/10.1016/j.chest.2017.05.009

    Article  PubMed  PubMed Central  Google Scholar 

  38. Ogilvie RP, Patel SR (2018) The epidemiology of sleep and diabetes. Curr Diab Rep 18(10):82. https://doi.org/10.1007/s11892-018-1055-8

    Article  PubMed  PubMed Central  Google Scholar 

  39. Mols F, Oerlemans S, Vos AH, Koster A, Verelst S, Sonneveld P, van de Poll-Franse LV (2012) Health-related quality of life and disease-specific complaints among multiple myeloma patients up to 10 yr after diagnosis: results from a population-based study using the PROFILES registry. Eur J Haematol 89(4):311–319. https://doi.org/10.1111/j.1600-0609.2012.01831.x

    Article  PubMed  Google Scholar 

  40. Kamal M, Wang XS, Shi Q, Zyczynski TM, Davis C, Williams LA, Lin HK, Garcia-Gonzalez A, Cleeland CS, Orlowski R (2021) Symptom burden and its functional impact in patients with “symptomatic” relapsed or refractory multiple myeloma. Support Care Cancer 29(1):467–475. https://doi.org/10.1007/s00520-020-05493-y

    Article  PubMed  Google Scholar 

  41. Hwang KH, Cho OH, Yoo YS (2016) Symptom clusters of ovarian cancer patients undergoing chemotherapy, and their emotional status and quality of life. Eur J Oncol Nurs 21:215–222. https://doi.org/10.1016/j.ejon.2015.10.007

    Article  PubMed  Google Scholar 

  42. Baden M, Lu L, Drummond FJ, Gavin A, Sharp L (2020) Pain, fatigue and depression symptom cluster in survivors of prostate cancer. Support Care Cancer 28(10):4813–4824. https://doi.org/10.1007/s00520-019-05268-0

    Article  PubMed  PubMed Central  Google Scholar 

  43. Nho JH, Kim SR, Park MH, Kweon SS (2018) Symptom clusters and quality of life in breast cancer survivors after cancer treatment in a tertiary hospital in Korea. Eur J Cancer Care (Engl) 27(6):e12919. https://doi.org/10.1111/ecc.12919

    Article  Google Scholar 

Download references

Funding

This work was supported by grants to F.C. from the West China Nursing Discipline Development Special Fund Project of Sichuan University (grant number HXHL19039) and Sichuan Provincial Health Committee Research Grant (grant number 16PJ350) and grants to Y.Z. from the National Science Foundation of China (grant number 82070219), Science and Technology Department of Sichuan Province (grant number 2019YJ0028), and the Sichuan University Faculty Start Fund.

Author information

Authors and Affiliations

Authors

Contributions

Conceptualization: Yamei Leng; methodology: Fengjiao Chen; formal analysis and investigation: Jingyao Ni, Li Zhang; writing (original draft preparation): Fengjiao Chen; writing (review and editing): Yuhuan Zheng, Jiping Li; funding acquisition: Fengjiao Chen, Yuhuan Zheng; resources: Yamei Leng, Ting Niu; supervision: Jiping Li.

Corresponding authors

Correspondence to Jiping Li or Yuhuan Zheng.

Ethics declarations

Ethics approval

Approval was obtained from the Biomedical Research Ethical Committee of West China Hospital (no. 2019504). The procedures used in this study adhere to the tenets of the Declaration of Helsinki.

Consent to participate

Informed consent was obtained from all individual participants included in the study.

Consent for publication

Not applicable.

Conflict of interest

The authors declare no competing interests.

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Chen, F., Leng, Y., Ni, J. et al. Symptom clusters and quality of life in ambulatory patients with multiple myeloma. Support Care Cancer 30, 4961–4970 (2022). https://doi.org/10.1007/s00520-022-06896-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00520-022-06896-9

Keywords

Navigation